2026. Efficacy of Dapagliflozin versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. World Journal of Current Medical and Pharmaceutical Research. 8, 2 (Aug. 2026), 185–189. DOI:https://doi.org/10.37022/wjcmpr.v8i2.415.